NASDAQ: MRNA - Moderna

Yield per half year: -39.51%
Dividend yield: 0%
Sector: Healthcare

Share chart Moderna

Extended chart Simple chart
Financial Markets by TradingView

About Moderna

Moderna — американская биотехнологическая компания, занимающаяся исследованием и разработкой лекарств на основе исключительно РНК-мессенджера. В основе компании идея с mRNA — мессенджер РНК. Искуственно создается возбудитель вируса и создается препарат, который тренирует иммунную систему. Надо только расшифровать геном вируса, загрузить в комп, и на выходе будет состав вакцины. И так практически с любым вирусом. Проблема с доставкой этого мРНК в клетки человека. У Модерны 21 разработка, 10 проходят клинические испытания и НОЛЬ одобренных препаратов.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2018-12-07
ISIN US60770K1079
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.modernatx.com
Цена ао 25.7
Change price per day: -0.8171% (25.7)
Change price per week: +4.34% (24.43)
Change price per month: -2.71% (26.2)
Change price per 3 month: -17.59% (30.93)
Change price per half year: -39.51% (42.14)
Change price per year: -80.14% (128.32)
Change price per 3 year: -81.82% (140.18)
Change price per 5 year: -80.54% (131.02)
Change price per year to date: -36.7% (40.27)
All parameters

Underestimation

Title Value Grade
P/S 4.67 3
P/BV 1.39 9
P/E 8.96 9
EV/EBITDA -4.1 0
Total: 6.25

Efficiency

Title Value Grade
ROA, % -21.87 0
ROE, % -28.77 0
Total: 1.67

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.0386

Debt

Title Value Grade
Debt/EBITDA -0.2092 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 1078.87 10
Yield Ebitda, % 344.76 10
Yield EPS, % 373.13 10
Total: 8
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
09.12.2024 09.12.2024 Klinger Shannon Thyme
Officer		 Purchase 44.68 23 636 529 0 0 link
03.12.2024 03.12.2024 Hoge Stephen
Officer		 Purchase 43.3 13 596 314 0 0 link
09.09.2024 10.09.2024 Klinger Shannon Thyme
Chief Legal Officer		 Sale 73.57 40 537 551 0 0 link
15.07.2024 16.07.2024 Hoge Stephen
President		 Sale 121.12 1 816 800 15000 0 0 link
17.06.2024 18.06.2024 Hoge Stephen
President		 Sale 138.16 2 072 400 15000 0 0 link
11.06.2024 11.06.2024 AFEYAN NOUBAR
Director		 Sale 148.34 30 088 100 202832 0 -0.05 link
10.06.2024 11.06.2024 Klinger Shannon Thyme
Chief Legal Officer		 Sale 148.09 766 810 5178 0 0 link
28.05.2024 29.05.2024 Klinger Shannon Thyme
Chief Legal Officer		 Sale 162.47 210 561 1296 0 0 link
22.05.2024 24.05.2024 AFEYAN NOUBAR
Director		 Sale 157.57 2 363 550 15000 0 0 link
15.05.2024 17.05.2024 AFEYAN NOUBAR
Director		 Sale 127.32 1 909 800 15000 0 0 link
10.05.2024 13.05.2024 Hoge Stephen
President		 Sale 120.96 30 845 255 0 0 link
08.05.2024 10.05.2024 AFEYAN NOUBAR
Director		 Sale 121.68 1 825 200 15000 0 0 link
01.05.2024 03.05.2024 AFEYAN NOUBAR
Director		 Sale 110.92 1 663 800 15000 0 0 link
24.04.2024 26.04.2024 AFEYAN NOUBAR
Director		 Sale 108.32 1 624 800 15000 0 0 link
17.04.2024 19.04.2024 AFEYAN NOUBAR
Director		 Sale 103.38 1 550 700 15000 0 0 link
15.04.2024 16.04.2024 Hoge Stephen
President		 Sale 105.02 1 575 300 15000 0 0 link
10.04.2024 12.04.2024 AFEYAN NOUBAR
Director		 Sale 107.12 1 606 800 15000 0 0 link
08.04.2024 09.04.2024 Mock James M
Chief Financial Officer		 Sale 101.93 71 861 705 0 0 link
03.04.2024 05.04.2024 AFEYAN NOUBAR
Director		 Sale 101.68 1 525 200 15000 0 0 link
27.03.2024 29.03.2024 AFEYAN NOUBAR
Director		 Sale 109.06 1 635 900 15000 0 0 link
20.03.2024 22.03.2024 AFEYAN NOUBAR
Director		 Sale 102.39 1 535 850 15000 0 0 link
13.03.2024 15.03.2024 AFEYAN NOUBAR
Director		 Sale 108.54 1 628 100 15000 0 0 link
20.09.2023 22.09.2023 AFEYAN NOUBAR
Director		 Sale 104.74 1 571 100 15000 0 0 link
15.09.2023 18.09.2023 Hoge Stephen
President		 Sale 112.99 1 694 850 15000 0 0 link
08.09.2023 11.09.2023 Klinger Shannon Thyme
Chief Legal Officer		 Sale 107.22 59 722 557 0 0 link
06.09.2023 08.09.2023 AFEYAN NOUBAR
Director		 Sale 107.61 1 614 150 15000 0 0 link
30.08.2023 01.09.2023 AFEYAN NOUBAR
Director		 Sale 115.46 1 731 900 15000 0 0 link
23.08.2023 25.08.2023 AFEYAN NOUBAR
Director		 Sale 115.51 1 732 650 15000 0 0 link
16.08.2023 18.08.2023 AFEYAN NOUBAR
Director		 Sale 97.56 975 600 10000 0 0 link
02.08.2023 04.08.2023 AFEYAN NOUBAR
Director		 Sale 110.99 1 664 850 15000 0 0 link
26.07.2023 28.07.2023 AFEYAN NOUBAR
Director		 Sale 120.42 1 806 300 15000 0 0 link
19.07.2023 21.07.2023 AFEYAN NOUBAR
Director		 Sale 125.48 1 882 200 15000 0 0 link
12.07.2023 14.07.2023 AFEYAN NOUBAR
Director		 Sale 125.81 1 887 150 15000 0 0 link
05.07.2023 07.07.2023 AFEYAN NOUBAR
Director		 Sale 124.73 1 870 950 15000 0 0 link
28.06.2023 30.06.2023 AFEYAN NOUBAR
Director		 Sale 121.54 1 823 100 15000 0 0 link
21.06.2023 23.06.2023 AFEYAN NOUBAR
Director		 Sale 121.95 1 829 250 15000 0 0 link
07.06.2023 09.06.2023 AFEYAN NOUBAR
Director		 Sale 125.91 1 888 650 15000 0 0 link
31.05.2023 02.06.2023 AFEYAN NOUBAR
Director		 Sale 127.35 1 910 250 15000 0 0 link
20.04.2023 21.04.2023 Bancel Stephane
Chief Executive Officer		 Sale 142.99 5 719 600 40000 0 -0.01 link
20.04.2023 21.04.2023 Bancel Stephane
Chief Executive Officer		 Purchase 0.99 39 600 40000 0 0.01 link
19.04.2023 21.04.2023 Bancel Stephane
Chief Executive Officer		 Sale 142.88 5 715 200 40000 0 -0.01 link
19.04.2023 21.04.2023 Bancel Stephane
Chief Executive Officer		 Purchase 0.99 39 600 40000 0 0.01 link
18.01.2023 20.01.2023 AFEYAN NOUBAR
Director		 Sale 200.2 2 002 000 10000 0 0 link
11.01.2023 13.01.2023 AFEYAN NOUBAR
Director		 Sale 188.57 1 885 700 10000 0 0 link
21.12.2022 23.12.2022 AFEYAN NOUBAR
Director		 Sale 201.7 2 017 000 10000 0 0 link
21.12.2022 23.12.2022 Andres Juan
See remarks		 Sale 201.7 403 400 2000 0 0 link
21.12.2022 23.12.2022 Andres Juan
See remarks		 Purchase 20.93 41 860 2000 0 0 link
23.11.2022 25.11.2022 AFEYAN NOUBAR
Director		 Sale 178.01 1 780 100 10000 0 0 link
02.11.2022 04.11.2022 AFEYAN NOUBAR
Director		 Sale 154.2 1 542 000 10000 0 0 link
26.10.2022 28.10.2022 AFEYAN NOUBAR
Director		 Sale 137.25 1 372 500 10000 0 0 link
19.10.2022 21.10.2022 AFEYAN NOUBAR
Director		 Sale 132.5 1 325 000 10000 0 0 link
12.10.2022 14.10.2022 AFEYAN NOUBAR
Director		 Sale 135.36 1 353 600 10000 0 0 link
05.10.2022 07.10.2022 AFEYAN NOUBAR
Director		 Sale 122.4 1 224 000 10000 0 0 link
28.09.2022 30.09.2022 AFEYAN NOUBAR
Director		 Sale 123.58 1 235 800 10000 0 0 link
21.09.2022 23.09.2022 AFEYAN NOUBAR
Director		 Sale 130.37 1 303 700 10000 0 0 link
14.09.2022 16.09.2022 AFEYAN NOUBAR
Director		 Sale 134 1 340 000 10000 0 0 link
07.09.2022 09.09.2022 AFEYAN NOUBAR
Director		 Sale 129.68 1 296 800 10000 0 0 link
31.08.2022 02.09.2022 AFEYAN NOUBAR
Director		 Sale 136.95 1 369 500 10000 0 0 link
17.08.2022 19.08.2022 AFEYAN NOUBAR
Director		 Sale 165.24 1 652 400 10000 0 0 link
10.08.2022 12.08.2022 AFEYAN NOUBAR
Director		 Sale 174.09 1 740 900 10000 0 0 link
10.08.2022 11.08.2022 Hoge Stephen
President		 Sale 173.66 42 373 244 0 0 link
09.08.2022 11.08.2022 Hoge Stephen
President		 Purchase 171.81 89 685 522 0 0 link
03.08.2022 05.08.2022 AFEYAN NOUBAR
Director		 Sale 167.99 1 679 900 10000 0 0 link
27.07.2022 29.07.2022 AFEYAN NOUBAR
Director		 Sale 161 1 610 000 10000 0 0 link
25.07.2022 26.07.2022 Hoge Stephen
President		 Sale 162.75 1 627 500 10000 0 0 link
20.07.2022 22.07.2022 AFEYAN NOUBAR
Director		 Sale 167 1 670 000 10000 0 0 link
13.07.2022 15.07.2022 AFEYAN NOUBAR
Director		 Sale 168.88 1 688 800 10000 0 0 link
06.07.2022 08.07.2022 AFEYAN NOUBAR
Director		 Sale 154.85 1 548 500 10000 0 0 link
29.06.2022 01.07.2022 AFEYAN NOUBAR
Director		 Sale 140.47 1 404 700 10000 0 0 link
24.06.2022 27.06.2022 Hoge Stephen
President		 Sale 143.98 719 900 5000 0 0 link
24.06.2022 27.06.2022 Hoge Stephen
President		 Purchase 10.9 54 500 5000 0 0 link
23.06.2022 27.06.2022 Hoge Stephen
President		 Sale 135.96 679 800 5000 0 0 link
23.06.2022 27.06.2022 Hoge Stephen
President		 Purchase 10.9 54 500 5000 0 0 link
22.06.2022 24.06.2022 AFEYAN NOUBAR
Director		 Sale 127.69 1 276 900 10000 0 0 link
08.06.2022 10.06.2022 AFEYAN NOUBAR
Director		 Sale 147.47 1 474 700 10000 0 0 link
25.05.2022 27.05.2022 AFEYAN NOUBAR
Director		 Sale 130.8 1 308 000 10000 0 0 link
18.05.2022 20.05.2022 AFEYAN NOUBAR
Director		 Sale 138.38 1 383 800 10000 0 0 link
14.04.2022 15.04.2022 Bancel Stephane
Chief Executive Officer		 Sale 168.59 1 685 900 10000 0 0 link
13.04.2022 15.04.2022 Andres Juan
See remarks		 Sale 158.37 316 740 2000 0 0 link
13.04.2022 15.04.2022 Andres Juan
See remarks		 Purchase 14.22 28 440 2000 0 0 link
13.04.2022 15.04.2022 Bancel Stephane
Chief Executive Officer		 Sale 170.26 1 532 340 9000 0 0 link
03.02.2022 04.02.2022 Bancel Stephane
Chief Executive Officer		 Sale 165 1 650 000 10000 0 0 link
02.02.2022 04.02.2022 Bancel Stephane
Chief Executive Officer		 Sale 170.89 1 538 010 9000 0 0 link
24.01.2022 25.01.2022 Hoge Stephen
President		 Sale 150.67 3 013 400 20000 0 0 link
24.01.2022 25.01.2022 Hoge Stephen
President		 Purchase 5.95 119 000 20000 0 0 link
20.01.2022 21.01.2022 Bancel Stephane
Chief Executive Officer		 Sale 175.01 1 750 100 10000 0 0 link
19.01.2022 21.01.2022 Bancel Stephane
Chief Executive Officer		 Sale 188.55 1 696 950 9000 0 0 link
22.11.2021 23.11.2021 Andres Juan
See remarks		 Sale 268.18 4 022 700 15000 0 0 link
22.11.2021 23.11.2021 Andres Juan
See remarks		 Purchase 13.55 203 250 15000 0 0 link
19.11.2021 23.11.2021 Andres Juan
See remarks		 Sale 265.71 1 328 550 5000 0 0 link
19.11.2021 23.11.2021 Andres Juan
See remarks		 Purchase 12.21 61 050 5000 0 0 link
16.06.2021 21.06.2021 Zaks Tal Zvi
Chief Medical Officer		 Sale 200 1 000 000 5000 0 0 link
16.06.2021 21.06.2021 Zaks Tal Zvi
Chief Medical Officer		 Purchase 25.93 129 650 5000 0 0 link
31.03.2021 31.03.2021 AFEYAN NOUBAR
Director		 Sale 121.07 591 790 4888 0 0 link
30.03.2021 31.03.2021 AFEYAN NOUBAR
Director		 Sale 118.97 251 359 000 2112795 0 -0.64 link
29.03.2021 31.03.2021 AFEYAN NOUBAR
Director		 Sale 124.6 203 736 000 1635122 0 -0.5 link
23.03.2021 25.03.2021 HENDERSON LORI M.
General Counsel and Secretary		 Sale 145.55 960 630 6600 0 0 link
23.03.2021 25.03.2021 HENDERSON LORI M.
General Counsel and Secretary		 Purchase 20.93 138 138 6600 0 0 link

Institutions Volume Share, %
Baillie Gifford and Company 45654527 11.92
Vanguard Group Inc 33907072 8.86
Blackrock Inc. 25301692 6.61
State Street Corporation 14623723 3.82
Flagship Pioneering Inc. 9666038 2.52
Theleme Partners LLP 7349456 1.92
Wellington Management Group, LLP 7225579 1.89
Geode Capital Management, LLC 6549461 1.71
FMR, LLC 6393351 1.67
Goldman Sachs Group Inc 4551626 1.19

ETF Share, % Profitability for 1 year, % Dividends, %
Amplify Treatments Testing and Advancements ETF 8.85 10.31 1.06
Direxion mRNA ETF 5.95 0
Apex Healthcare ETF 4.49 0
iShares Evolved U.S. Innovative Healthcare ETF 4.38 0.000586 2.79
Future Tech ETF 2.44975 426.34 0.8416
Principal Healthcare Innovators ETF 2.44975 618.5 0.8416
Nationwide Maximum Diversification U.S. Core Equity ETF 1.6 26.65 1.58
Collaborative Investment Series Trust Trend Aggregation US Fund 1.38 4.03 20.07
iShares Russell 1000 Pure U.S. Revenue ETF 1.15 35.03 1.87
Pacer BioThreat Strategy ETF 0.85768 14.04 1.65371
Harbor Disruptive Innovation ETF 0.74671 29.05 0.39896
AGFiQ US Market Neutral Momentum Fund 0.71 -16.42 2.58
iShares Morningstar Mid-Cap ETF 0.20441 5.2 1.7458
Fidelity Growth Opportunities ETF 0.18722 4.03 0.48881
Nationwide Nasdaq-100 Risk-Managed Income ETF 0.18182 21.38 0.87606
iShares Morningstar Mid-Cap Growth ETF 0.17771 9.66 0.94237
iShares Morningstar Large-Cap Value ETF 0.0486 5.98 2.17567
iShares Morningstar Large-Cap ETF 0.04363 257.57 1.41244
Columbia U.S. ESG Equity Income ETF 0.04085 -99.18 1.44131
iShares Morningstar Large-Cap Growth ETF 0.03916 12.73 0.5823
iShares Factors US Growth Style ETF 0.0316 6.78 0.7035



Head Job title Payment Year of birth
Mr. Stephane Bancel CEO & Director 4.55M 1973 (52 years)
Ms. Lavina Talukdar CFA Senior VP & Head of Investor Relations N/A
Ms. Shannon Thyme Klinger Chief Legal Officer & Corporate Secretary 1.39M 1971 (54 years)
Dr. Stephen Hoge M.D. President 1.92M 1977 (48 years)
Mr. James M. Mock Chief Financial Officer 1.4M 1977 (48 years)
Dr. Jerh Collins Ph.D. Chief Technical Operations & Quality Officer N/A 1967 (58 years)
Mr. Brad Miller Chief Information Officer N/A 1974 (51 year)
Colleen Hussey Senior Director of Corporate Communications N/A
Ms. Tracey Franklin Chief Human Resources Officer N/A 1981 (44 years)
Dr. Melanie Ivarsson M.B.A., Ph.D. Chief Development Officer N/A

Address: United States, Cambridge, 200 Technology Square - open in Google maps, open in Yandex maps
Website: http://www.modernatx.com